From AI to Endo: What’s Shaping Women’s Health Now

Good Morning!

This week’s issue spans the spectrum of women’s health: the promise of AI, the persistence of censorship, and the power of research to finally close long-standing gaps.

I’m preparing an interview on AI in women’s health—but not all AI is created equal, and the type of platform (LLMs vs. predictive models) matters for the quality of output. I want to hear your questions.

I also sat down with Saundra Pelletier, CEO of Evofem Biosciences, to talk about why female anatomy still gets censored online and in public spaces—and what we can do to push back.

Plus, I’ll be moderating a fireside chat on the EMMA Study, a national effort using biomarker data and patient voices to transform how endometriosis is diagnosed and treated.

And as always, here’s what I’m curious about this week: UK approval of testosterone therapy for women, Venus Williams’ powerful fibroid journey, new research on aging, a $3M gift to advance women’s heart health, and even tunnel skating in NYC.

Let’s get into it.

SPOTLIGHT

🤔 Why Women’s Health Keeps Getting Censored

Last week, TikTok banned one of my posts. My “violation”? Showing an anatomically correct clitoris model as part of a women’s health education quiz. No explicit words. No graphic content. Just science. (NOTE: I had to hyperlink to Instagram which did not ban the post.)

If I had used male anatomy, it likely would have stayed up. That double standard is everywhere — even the MTA once rejected ads for women’s health while approving men’s sexual health campaigns.

This is exactly why Saundra Pelletier, CEO of Evofem Biosciences, created #SayVaginaMonth. We sat down for a powerful conversation on:

🚫 Why female anatomy gets censored — while male terms don’t

🩺 How language shapes women’s health outcomes

👩‍⚕️ Why even doctors avoid sexual health conversations

📣 What you can do to push back against bans and spread awareness

👉 Watch the full interview or Listen to it
👉 Catch the 2-min Short on the MTA ad ban 

‼️ And if you’re fired up, comment on these posts on LinkedIn and Instagram and share them — because sharing is what changes the algorithm and makes sure women’s health content doesn’t stay in the shadows. ‼️

EVENT

📣 A Breakthrough in Women’s Health Research

Endometriosis affects millions—but too often, it takes years to diagnose and leaves patients with more questions than answers. The EMMA Study is working to change that.

Join me for a virtual fireside chat with Dr. Idhaliz Flores, Principal Investigator of the EMMA (Endometriosis Multi-Omics Multi-Center Assessment) Study, and learn how this groundbreaking research is using unique biomarker data, clinical information, and patient experiences to revolutionize how endometriosis is understood, diagnosed, and treated.

👉 Register here to join the conversation

During our discussion, Dr. Flores will share:

• What makes the EMMA Study different from past research

• How participants are shaping the future of care

• What scientists are uncovering through this national effort

This is a rare opportunity for patients, researchers, clinicians, and advocates to get a behind-the-scenes look at one of the most innovative endometriosis studies in the U.S.

About Dr. Idhaliz Flores

Dr. Flores is Chief Scientific Officer for Nura Health and Director of the Endometriosis Research Program at Ponce Research Institute. Since 2001, her NIH-funded work has focused on identifying biomarkers and developing non-invasive diagnostics. She also serves on the board of the Fundación Puertorriqueña de Pacientes con Endometriosis, advocating for women’s health in Puerto Rico.

✨ Get Involved Beyond the Event

• Explore Fempower Health’s curated endometriosis resources to help you better navigate care.

• Learn about our Endometriosis Working Group—an initiative driving systemic change. (I’m thrilled so many of you have already filled out the survey, and I’m engaging directly with the World Endometriosis Society to bring your voices forward.)

COMING SOON

🎧 AI in Women’s Health

AI is everywhere right now—but when it comes to healthcare, the hype often overshadows the reality. Do we really understand the nuances in the AI platforms being used—from large language models (LLMs) to predictive analytics—and how those differences shape the quality, safety, and reliability of the output?

I’m recording an upcoming interview on this topic, and I’d love to hear what questions you want answered.

👉 Share your questions in the LinkedIn post here

(You can also find the video on Youtube, TikTok and Instagram if that’s where you prefer to join the conversation.)

🙌🏼 What Caught My Eye This Week

🧬 Testosterone for Women Approved in the UK
For the first time, the UK has approved testosterone therapy for women — a milestone that could reshape menopause and hormone care. Here’s why this is huge news.
👉 Learn more

🎾 Venus Williams’ Fibroid Story
One year ago, she underwent major surgery for fibroids and adenomyosis. Today, she’s back on the court and speaking out so other women don’t have to suffer in silence. A powerful reminder to advocate for your health.
👉 Read her post

⏳ Why We Age the Way We Do
Hidden Brain dives deep into the science of aging — and what it means for how we live longer, healthier lives.
👉 Listen here

❤️ A $3 Million Gift for Women’s Hearts
The American Heart Association just received a transformational $3M gift to expand the Go Red for Women® Venture Fund. Here’s why it matters for the future of women’s heart health.
👉 Read more

⛸️ Tunnel Skating in NYC
A surreal, high-energy activity transforming the city’s underground spaces. Is this the coolest new way to move in New York?
👉 Check it out

👉 Have something for me to share with this group? Reply to this email. 🙏🏼